N-(4-Chlorophenyl)-4-hydroxy-1-methyl-1H-thieno[3,2-c][1,2]thiazine-3-carbothioamide 2,2-dioxide

Catalog No. :
ACFCPJ753
CAS No. :
320423-76-5
Molecular Formula :
C14H11ClN2O3S3
Molecular Weight :
386.91

IUPAC Name:N-(4-chlorophenyl)-4-hydroxy-1-methyl-1H-thieno[3,2-c][1,2]thiazine-3-carbothioamide 2,2-dioxide

N-(4-Chlorophenyl)-4-hydroxy-1-methyl-1H-thieno[3,2-c][1,2]thiazine-3-carbothioamide 2,2-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$564.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Chlorophenyl)-4-hydroxy-1-methyl-1H-thieno[3,2-c][1,2]thiazine-3-carbothioamide 2,2-dioxide
IUPAC NameN-(4-chlorophenyl)-4-hydroxy-1-methyl-1H-thieno[3,2-c][1,2]thiazine-3-carbothioamide 2,2-dioxide
Molecular FormulaC14H11ClN2O3S3
Molecular Weight386.91
SMILESS=C(NC1=CC=C(C=C1)Cl)C2=C(C3=C(N(S2(=O)=O)C)C=CS3)O
InChI KeyOIXDGQDMKITYHV-UHFFFAOYSA-N
SynonymN-(4-CHLOROPHENYL)-4-HYDROXY-1-METHYL-2,2-DIOXO-1,2-DIHYDRO-2LAMBDA6-THIENO[3,2-C][1,2]THIAZINE-3-CARBOTHIOAMIDE;N-(4-Chlorophenyl)-4-hydroxy-1-methyl-2,2-dioxo-1,2-dihydro-2lambda~6~-thieno[3,2-c][1,2]thiaz;1H-Thieno[3,2-c][1,2]thiazine-3-carbothioamide, N-(4-chlorophenyl)-4-hydroxy-1-methyl-, 2,2-dioxide
CAS No.320423-76-5

Synthetic Route by SureRoute

1. ACFCPJ753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFCPJ753 route product structure diagram
    ACFCPJ753320423-76-5
Inquiry

2. ACFCPJ753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFCPJ753 route product structure diagram
    ACFCPJ753320423-76-5
Inquiry

Comments (0)